Although the RR was not statistically significant, this may suggest a positive trend for sparsentan in reducing the risk of composite renal failure endpoints from a clinical perspective.
1
—
—
Although the RR was not statistically significant, this may suggest a positive trend for sparsentan in reducing the risk of composite renal failure endpoints from a clinical perspective.